CLINICAL_TRIALS
trial_result
· 2008-01-15
Clinical Trial Update: Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
Summary
A Phase 3 trial comparing TLK286 (Telcyta) to Gefitinib in locally advanced or metastatic non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Telik | Conditions: Non Small Cell Lung Carcinoma | Phase 3 | Status: COMPLETED